|Articles|April 1, 1998

April 1998
Volume 4
Issue 4

Cost of Migraine Management: A Pharmacoeconomic Overview

Author(s)Alan M. Rapoport, MD, James U. Adelman, MD

Download PDF: Cost of Migraine Management: A Pharmacoeconomic Overview

Articles in this issue

almost 28 years ago

Article

A Program to Reduce Discharge Delays in a Neonatal Intensive Care Unit

almost 28 years ago

Article

Attitudes and Behavioral Intentions Regarding Managed Care: A Comparison of Academic and Community Physicians

almost 28 years ago

Article

Physician and Dietitian Prescribing of a Commercially Available Oral Nutritional Supplement

almost 28 years ago

Article

A New Gatekeeper for Back Pain

almost 28 years ago

Article

Influencing Physicians: The Three Critical Elements of a Successful Strategy

almost 28 years ago

Article

Alzheimer's Disease: Clinical Features and Pharmacologic Management

almost 28 years ago

Article

Medicare HMOs: Who Joins and Who Leaves?

almost 28 years ago

Article

Changes in Benefit Payments and Health Insurance Premiums Among Firms Switching Health Insurance Carriers

Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.

Subscribe Now!

Latest CME

Online Article

Innovations in Medicine: 2024 Lineup of New and Approved Specialty Drugs

2.0 Credits / General Pharmacy

AJMC Supplement

Revolutionizing Acute Pain Relief: Emerging Nonopioid Therapies and the Essential Role of Managed Care

2.0 Credits / Pain Management

Cost of Migraine Management: A Pharmacoeconomic Overview

Articles in this issue

Newsletter

Related Content

Quality of Life: The Pending Outcome in Idiopathic Pulmonary Fibrosis

Increased Payments to Medicare Advantage Plans for Dually Eligible Beneficiaries

The Health Information Technology Special Issue: Tracking Expansion Across Settings, Technologies, and Stakeholders

Building Trust: Public Priorities for Health Care AI Labeling

Ambient AI Tool Adoption in US Hospitals and Associated Factors

Latest CME

Innovations in Medicine: 2024 Lineup of New and Approved Specialty Drugs

Revolutionizing Acute Pain Relief: Emerging Nonopioid Therapies and the Essential Role of Managed Care

Trending on AJMC

TrumpRx Launch Brings Savings—and Uncertainty

5 Things to Know About the Oral GLP-1 Era

Stroke Subtype Does Not Affect Efficacy of Asundexian for Second Stroke Prevention

How Do GLP-1 Agonists Fit Into Stroke Care?

Exploring Identity, Appearance Experiences Among Patients With Alopecia